<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName journalpublishing.dtd?>
<?SourceDTD.Version 2.3?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 2?>
<front>
  <?epub May-15-2013?>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-id journal-id-type="hwp">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">3692055</article-id>
    <article-id pub-id-type="pmid">23677608</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkt391</article-id>
    <article-id pub-id-type="publisher-id">gkt391</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Articles</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>BAGEL3: automated identification of genes encoding bacteriocins and (non-)bactericidal posttranslationally modified peptides</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>van Heel</surname>
          <given-names>Auke J.</given-names>
        </name>
        <xref ref-type="aff" rid="gkt391-AFF1">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="gkt391-AFF1">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>de Jong</surname>
          <given-names>Anne</given-names>
        </name>
        <xref ref-type="aff" rid="gkt391-AFF1">
          <sup>1</sup>
        </xref>
        <xref ref-type="corresp" rid="gkt391-COR1">*</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Montalbán-López</surname>
          <given-names>Manuel</given-names>
        </name>
        <xref ref-type="aff" rid="gkt391-AFF1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kok</surname>
          <given-names>Jan</given-names>
        </name>
        <xref ref-type="aff" rid="gkt391-AFF1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kuipers</surname>
          <given-names>Oscar P.</given-names>
        </name>
        <xref ref-type="aff" rid="gkt391-AFF1">
          <sup>1</sup>
        </xref>
        <xref ref-type="aff" rid="gkt391-AFF1">
          <sup>2</sup>
        </xref>
        <xref ref-type="corresp" rid="gkt391-COR2">*</xref>
      </contrib>
    </contrib-group>
    <aff id="gkt391-AFF1"><sup>1</sup>Molecular Genetics, University of Groningen, Linnaeusborgh, Nijenborgh 7, 9747AG Groningen, The Netherlands and <sup>2</sup>Kluyver Center for Genomics of Industrial Fermentation, Groningen/Delft, The Netherlands</aff>
    <author-notes>
      <corresp id="gkt391-COR1">*To whom correspondence should be addressed. Tel: <phone>+31 50 363 2047</phone>; Email: <email>anne.de.jong@rug.nl</email></corresp>
      <corresp id="gkt391-COR2">Correspondence may also be addressed to Oscar P. Kuipers. Tel: <phone>+31 50 363 2093</phone>; Fax: <fax>+31 503 63 2348</fax>; Email: <email>o.p.kuipers@rug.nl</email></corresp>
      <fn>
        <p>The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="ppub">
      <month>7</month>
      <year>2013</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>15</day>
      <month>5</month>
      <year>2013</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>15</day>
      <month>5</month>
      <year>2013</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
    <volume>41</volume>
    <issue>Web Server issue</issue>
    <fpage>W448</fpage>
    <lpage>W453</lpage>
    <history>
      <date date-type="received">
        <day>18</day>
        <month>2</month>
        <year>2013</year>
      </date>
      <date date-type="rev-recd">
        <day>11</day>
        <month>4</month>
        <year>2013</year>
      </date>
      <date date-type="accepted">
        <day>18</day>
        <month>4</month>
        <year>2013</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2013. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2013</copyright-year>
      <license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
        <license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p>
      </license>
    </permissions>
    <abstract>
      <p>Identifying genes encoding bacteriocins and ribosomally synthesized and posttranslationally modified peptides (RiPPs) can be a challenging task. Especially those peptides that do not have strong homology to previously identified peptides can easily be overlooked. Extensive use of BAGEL2 and user feedback has led us to develop BAGEL3. BAGEL3 features genome mining of prokaryotes, which is largely independent of open reading frame (ORF) predictions and has been extended to cover more (novel) classes of posttranslationally modified peptides. BAGEL3 uses an identification approach that combines direct mining for the gene and indirect mining via context genes. Especially for heavily modified peptides like lanthipeptides, sactipeptides, glycocins and others, this genetic context harbors valuable information that is used for mining purposes. The bacteriocin and context protein databases have been updated and it is now easy for users to submit novel bacteriocins or RiPPs. The output has been simplified to allow user-friendly analysis of the results, in particular for large (meta-genomic) datasets. The genetic context of identified candidate genes is fully annotated. As input, BAGEL3 uses FASTA DNA sequences or folders containing multiple FASTA formatted files. BAGEL3 is freely accessible at <ext-link ext-link-type="uri" xlink:href="http://bagel.molgenrug.nl">http://bagel.molgenrug.nl</ext-link>.</p>
    </abstract>
    <counts>
      <page-count count="6"/>
    </counts>
    <custom-meta-group>
      <custom-meta>
        <meta-name>cover-date</meta-name>
        <meta-value>1 July 2013</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec>
    <title>INTRODUCTION</title>
    <p>Scientific interest in bacterial antimicrobial peptides and other posttranslationally modified peptides is increasing (<xref ref-type="bibr" rid="gkt391-B1">1</xref>,<xref ref-type="bibr" rid="gkt391-B2">2</xref>). Finding new antibiotic compounds from novel sources to fight multi-drug resistant pathogens has become the focus of many researchers. Furthermore, knowledge about the diverse enzymes involved in posttranslational modifications is rapidly advancing (<xref ref-type="bibr" rid="gkt391-B3 gkt391-B4 gkt391-B5">3–5</xref>) and can be used to make new-to-nature antimicrobial peptides (<xref ref-type="bibr" rid="gkt391-B6">6</xref>,<xref ref-type="bibr" rid="gkt391-B7">7</xref>) or to stabilize medically relevant peptides (<xref ref-type="bibr" rid="gkt391-B8">8</xref>). The discovered world of ribosomally synthesized and posttranslationally modified peptides (RiPPs) is constantly expanding. More and more modifications and the enzymes involved are being described (<xref ref-type="bibr" rid="gkt391-B1">1</xref>). With the discovery of each new class new genome mining efforts are triggered. These efforts have led to valuable information and several high-impact publications (<xref ref-type="bibr" rid="gkt391-B4">4</xref>,<xref ref-type="bibr" rid="gkt391-B9 gkt391-B10 gkt391-B11 gkt391-B12">9–12</xref>). The main challenge in these kinds of genome mining efforts is the small size of the genes encoding the peptides of interest. Small open reading frames (ORFs) are often omitted during automated annotation efforts especially when their product sequences do not show strong homology with those of already described peptides, hampering a direct mining approach. Therefore, the large modification enzymes have been used regularly in indirect genome mining efforts. With the design and development of the BActeriocin GEnome mining tooL (BAGEL) since 2005, we aim to facilitate these efforts (<xref ref-type="bibr" rid="gkt391-B13">13</xref>,<xref ref-type="bibr" rid="gkt391-B14">14</xref>). Other useful tools have also been developed, such as the data repository Bactibase (<xref ref-type="bibr" rid="gkt391-B15">15</xref>) and the prediction tool antiSMASH (<xref ref-type="bibr" rid="gkt391-B16">16</xref>), which also supports non-ribosomal peptides but lacks some of the classes supported by the faster BAGEL3. In the current version of BAGEL, BAGEL3, our main goals were to combine direct and indirect mining, generate a simpler, clearer and better quality output, make the analysis more independent of ORF predictions and to facilitate the addition of novel classes of peptides that can be mined for.</p>
  </sec>
  <sec>
    <title>IMPLEMENTATION</title>
    <sec>
      <title>New in BAGEL3</title>
      <p>The major improvement in BAGEL3 is the new dual process (<xref ref-type="fig" rid="gkt391-F1">Figure 1</xref>), i.e. combining two mining strategies in one procedure. Another major advantage of BAGEL3 is its use of DNA sequences as input instead of annotated genomes, making it less dependent on ORF predictions. Furthermore, novel classes of RiPPs have been implemented, extending the genome mining capabilities of BAGEL3 beyond bacteriocins only. For this purpose new hidden Markov (HMM) models have been added describing specific genes involved in the biosynthesis of <underline>cya</underline>nobactins (called CyaG after PatG) (<xref ref-type="bibr" rid="gkt391-B17">17</xref>), <underline>sac</underline>tipeptides (called SacCD after TrnCD) (<xref ref-type="bibr" rid="gkt391-B18">18</xref>) and <underline>lin</underline>aridins (called LinL after CypL) (<xref ref-type="bibr" rid="gkt391-B10">10</xref>).
<fig id="gkt391-F1" position="float"><label>Figure 1.</label><caption><p>Schematic overview of the BAGEL3 genome mining procedure. BAGEL3 uses two different approaches in parallel to find bacteriocins and modified peptides. Both approaches use nucleotide sequences in FASTA format as input. The first approach (left, red) describes how the context-based approach proceeds. The second approach (right, blue) describes the simpler precursor peptide-based mining. Finally, both methods generate a single summary table with links to detailed graphical reports.</p></caption><graphic xlink:href="gkt391f1p"/></fig></p>
    </sec>
    <sec>
      <title>BAGEL3 databases</title>
      <p>BAGEL3 uses three different databases containing modified or unmodified bacteriocins and other posttranslationally modified peptides (non-bactericidal). The databases have been thoroughly updated. Each database contains all the records belonging to one of the three classes of proteins internal to BAGEL3: Class I contains posttranslationally modified peptides &lt;10 kDa, the modification enzymes of which are encoded in the genomic context of the modified peptide and have been described for more than one case; Class II contains posttranslationally modified peptides &lt;10 kDa not fitting the criteria of the first database; Class III contains anti-microbial proteins &gt;10 kDa. This division is based on the procedure used by BAGEL3 to identify these proteins. The databases can be viewed online (<ext-link ext-link-type="uri" xlink:href="http://bagel.molgenrug.nl/index.php/bacteriocin-database/">http://bagel.molgenrug.nl/index.php/bacteriocin-database/</ext-link>) and have web links to literature, UniprotKB and NCBI. Users are actively encouraged to add new records to these databases via a web form (<ext-link ext-link-type="uri" xlink:href="http://bagel.molgenrug.nl/index.php/submit-a-bacteriocin">http://bagel.molgenrug.nl/index.php/submit-a-bacteriocin</ext-link>).</p>
    </sec>
    <sec>
      <title>Description of the software</title>
      <p>BAGEL3 uses DNA nucleotide sequences in FASTA format as input; multiple sequence entries per file are allowed. These DNA sequences are analyzed in parallel using two different approaches, one based on finding genes commonly found in the context of bacteriocin or RiPP genes, the other based on finding the gene itself.</p>
      <p>The indirect approach (left red box in <xref ref-type="fig" rid="gkt391-F1">Figure 1</xref>) starts with performing a simple ORF call on the DNA. This call looks for ORFs of a certain minimal length that have a start and a stop codon not taking into account the presence of a possible ribosome-binding site. The products of these ORFs are subsequently screened for the presence of protein domains. Simple and defined rules based on these protein domains are then used to decide which part of the nucleotide sequence should be analyzed in more detail. These DNA sequences are called area(s) of interest (AOI). The size of the area is set to 20 K base pairs centered on the identified context gene. The ORFs in the AOI are then called using Glimmer (<xref ref-type="bibr" rid="gkt391-B19">19</xref>). The next essential step is an additional specialized simple ORF call for every AOI to find the small ORFs that encode the targets of the identified modification enzymes. This ORF call takes into account the rule that was used to identify this AOI, so that when BAGEL3 is, for example, looking for a lanthipeptide, it will only call small ORFs encoding cysteine-containing peptides. Next, the context is annotated using the PFAM database (blast against Uniprot database is also possible in the stand-alone version). The last step is to identify the RiPP gene(s) that are present in the AOI. This is done using the results of both a Blast search against the BAGEL3 Class I and Class II databases and a screening for known motifs. If no direct hit is obtained then BAGEL3 predicts a precursor peptide sequence based on sequence properties and genomic organization.</p>
      <p>The direct approach (right blue in box <xref ref-type="fig" rid="gkt391-F1">Figure 1</xref>) starts with a Glimmer ORF call. Next, the ORFs are blasted against all the three databases. The context (20 K base pair) of Blast hits is annotated using the PFAM database (a blast against Uniprot database is also possible in the stand-alone version).</p>
      <p>Because the same peptide could be identified with both approaches, the results of both are compared and filtered to exclude duplicates. Peptides identified via context genes are classified using this information (<xref ref-type="table" rid="gkt391-T1">Table 1</xref>). Unmodified peptides identified via homology are classified according to their best Blast hit. Finally, an html output with graphics is generated from the large basic results table (see <xref ref-type="fig" rid="gkt391-F2">Figure 2</xref>). The whole process is logged into a log file. The nucleotide sequences of the identified AOIs can be downloaded.
<fig id="gkt391-F2" position="float"><label>Figure 2.</label><caption><p>Example detailed report of a lantibiotic cluster encoding a nisin variant and its modification enzymes found in <italic>Streptococcus suis</italic> J14 (NC_017618.1) using BAGEL3. The target gene (smallORF_6) was in this case identified by the specialized small ORF calling procedure.</p></caption><graphic xlink:href="gkt391f2p"/></fig>
<table-wrap id="gkt391-T1" position="float"><label>Table 1.</label><caption><p>Currently supported classes of RiPPs and the rules used to identify potential clusters</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Name</th><th rowspan="1" colspan="1">Rule</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Bottromycin</td><td rowspan="1" colspan="1">(PF04055) AND (PF02624)</td></tr><tr><td rowspan="1" colspan="1">Cyanobactin</td><td rowspan="1" colspan="1">(CyaG)</td></tr><tr><td rowspan="1" colspan="1">Glycocin</td><td rowspan="1" colspan="1">(TIGR04195) AND (PF03412)</td></tr><tr><td rowspan="1" colspan="1">Lanthipeptide class II</td><td rowspan="1" colspan="1">(PF05147) AND (PF13575)</td></tr><tr><td rowspan="1" colspan="1">Lanthipeptide class I</td><td rowspan="1" colspan="1">(PF04737|PF04738|PF14028) AND (PF05147)</td></tr><tr><td rowspan="1" colspan="1">Lanthipeptide class III</td><td rowspan="1" colspan="1">(lanKC)</td></tr><tr><td rowspan="1" colspan="1">Lanthipeptide class IV</td><td rowspan="1" colspan="1">(PF05147) AND (LanL)</td></tr><tr><td rowspan="1" colspan="1">LAPs</td><td rowspan="1" colspan="1">(PF02624) AND (PF00881)</td></tr><tr><td rowspan="1" colspan="1">Lasso peptide</td><td rowspan="1" colspan="1">(PF13471) AND (PF00733)</td></tr><tr><td rowspan="1" colspan="1">Linaridin</td><td rowspan="1" colspan="1">(LinL)</td></tr><tr><td rowspan="1" colspan="1">Microcin</td><td rowspan="1" colspan="1">(PF02794)</td></tr><tr><td rowspan="1" colspan="1">Sactipeptides</td><td rowspan="1" colspan="1">(SacCD) AND (PF04055)</td></tr><tr><td rowspan="1" colspan="1">Thiopeptide</td><td rowspan="1" colspan="1">(PF02624) AND (PF00881) AND (PF14028)</td></tr></tbody></table><table-wrap-foot><fn id="gkt391-TF1"><p>| = or AND = additional requirement. The rules in this table describe the criteria that have to be matched by a certain stretch of DNA to become an AOI. Some rules might overlap, and therefore they are checked in an ordered fashion. In this way, the more stringent rule is checked after the less stringent.</p></fn></table-wrap-foot></table-wrap></p>
    </sec>
    <sec>
      <title>Availability</title>
      <p>The BAGEL3 web server can be accessed and used freely for files up to 20 MB (<ext-link ext-link-type="uri" xlink:href="http://bagel.molgenrug.nl">http://bagel.molgenrug.nl</ext-link>). A stand-alone Linux version is available on request for local installation. The stand-alone version can be easily adapted to personal preferences using a comprehensive configuration file.</p>
    </sec>
    <sec>
      <title>System requirements</title>
      <p>BAGEL3 runs on an Ubuntu Linux platform (<ext-link ext-link-type="uri" xlink:href="http://www.ubuntu.com">http://www.ubuntu.com</ext-link>) with Apache web server (version2.2), MySQL server (version 14.14), PHP 5.4 (<ext-link ext-link-type="uri" xlink:href="http://www.php.net/">http://www.php.net/</ext-link>), Perl 5.10 (<ext-link ext-link-type="uri" xlink:href="http://www.perl.org/">http://www.perl.org/</ext-link>), BioPerl 1.6.9 (<ext-link ext-link-type="uri" xlink:href="http://www.bioperl.org/">http://www.bioperl.org/</ext-link>) and Joomla. Furthermore, the following software packages are used: BLAST 2.2.27 (<xref ref-type="bibr" rid="gkt391-B20">20</xref>); HMMsearch 3.0 (<ext-link ext-link-type="uri" xlink:href="http://hmmer.janelia.org/">http://hmmer.janelia.org/</ext-link>); Glimmer 3.02 (<ext-link ext-link-type="uri" xlink:href="http://www.cbcb.umd.edu/software/glimmer/">http://www.cbcb.umd.edu/software/glimmer/</ext-link>) (<xref ref-type="bibr" rid="gkt391-B19">19</xref>), Pfamscan of the Sanger institute (<ext-link ext-link-type="ftp" xlink:href="ftp://ftp.sanger.ac.uk/pub/databases/Pfam/Tools/">ftp://ftp.sanger.ac.uk/pub/databases/Pfam/Tools/</ext-link>) and the UniRef50 database (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/uniref/">http://www.ebi.ac.uk/uniref/</ext-link>).</p>
    </sec>
    <sec>
      <title>Validation of BAGEL 3</title>
      <p>The BAGEL3 software was validated using a set of 50 genomes known to encode bacteriocins and other modified peptides. It was checked that no known compounds were missed. Next, to validate if novel clusters could be identified, 200 draft genome sequences from the NCBI server were screened. Both these sets of genomes were also used to check for false positives. A false positive was defined as a cluster that did not have at least a likely core peptide or a gene context that can be associated with RiPP biosynthesis.</p>
    </sec>
  </sec>
  <sec>
    <title>RESULTS AND DISCUSSION</title>
    <sec>
      <title>Analysis of example genomes</title>
      <p>Based on the newly added HMM CyaG, which identifies the serine protease, generally termed G protein, in the cyanobactin biosynthesis pathway (<xref ref-type="bibr" rid="gkt391-B21">21</xref>), we found a new cyanobactin encoded in the genome of the cyanobacterium <italic>Lyngbya</italic> sp PCC8106 (see <xref ref-type="table" rid="gkt391-T2">Table 2</xref>). In <italic>Enterococcus faecalis</italic> Fly1, BAGEL3 identified an interesting novel lantibiotic gene cluster. The cluster could code for two lanthipeptides, which is common for two-component lantibiotics, but in this case they are not modified by a LanM type enzyme but by a single set of LanBC enzymes. Another example of the added value of BAGEL3 is demonstrated when querying the plasmid pTEF2 of <italic>E</italic><italic>. faecalis</italic> V538. Based on the context, BAGEL3 identifies a glycocin-like peptide (<xref ref-type="table" rid="gkt391-T2">Table 2</xref>). Glycocins are glycosylated antimicrobial peptides of which Glycocin S and Sublancin 168 are the only two characterized members that also contain disulfide bridges (<xref ref-type="bibr" rid="gkt391-B1">1</xref>). The identified peptide has an exact match with the previously described bacteriocin Enterocin 96 (<xref ref-type="bibr" rid="gkt391-B22">22</xref>). In the article describing Enterocin 96, the authors note that the measured mass is higher than the theoretical peptide mass. This mass difference is perfectly in line with the BAGEL3 predicted glycosylation, which has also been suggested by others (<xref ref-type="bibr" rid="gkt391-B23">23</xref>). In the genome of the honey bee pathogen <italic>Paenibacillus larvae</italic> subsp <italic>larvae</italic> BRL 230010, BAGEL3 identified the gene for a so-called sactipeptide that shows low homology to sporulation killing factor SfkA of <italic>Bacillus subtilis</italic> 168. In the genome of the gram negative pathogen <italic>Burkholderia pseudomallei</italic>, 354a, a lasso peptide, was identified with strong homology to capistruin (<xref ref-type="bibr" rid="gkt391-B24">24</xref>).
<table-wrap id="gkt391-T2" position="float"><label>Table 2.</label><caption><p>A selection of novel RIPPs identified by BAGEL3</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">DNA screened</th><th rowspan="1" colspan="1">Homology (<italic>P</italic>-value)</th><th rowspan="1" colspan="1">Identification</th><th rowspan="1" colspan="1">Sequence</th></tr></thead><tbody align="left"><tr><td rowspan="2" colspan="1"><italic>P. larvae</italic> subsp <italic>larvae</italic> BRL 230010 Ctg01135</td><td rowspan="2" colspan="1">Sporulation-killingfactor_skfA [1e-10]</td><td rowspan="2" colspan="1">Context: SacCD</td><td rowspan="1" colspan="1">Sactipeptide:</td></tr><tr><td rowspan="1" colspan="1">MSNHNVRNEPAPAWESSAQNNLSKPAGIPLIKSVGCAACWGAK NISLTRACLPPTPINLAL</td></tr><tr><td rowspan="3" colspan="1">pTEF2 <italic>E. fecalis</italic> V538</td><td rowspan="3" colspan="1">Enterocin_96 [2e-41] (exact match)</td><td rowspan="2" colspan="1">context: TIGR04195</td><td rowspan="1" colspan="1">Glycocin:</td></tr><tr><td rowspan="2" colspan="1">MLNKKLLENGVVNAVTIDELDAQFGGMSKRDCNL MKACCAGQAVTYAIHSLLNRLGGDSSDPAGCNDIVRKYCK</td></tr><tr><td rowspan="1" colspan="1">PF03412</td></tr><tr><td rowspan="3" colspan="1"><italic>E. faecalis</italic> Fly1 cont1.76</td><td rowspan="3" colspan="1">leader_abc mature_ab PF02052.7 leaderLanBC</td><td rowspan="1" colspan="1">context:</td><td rowspan="1" colspan="1">Lantibiotic:</td></tr><tr><td rowspan="1" colspan="1">PF04737.5 PF04738.5</td><td rowspan="2" colspan="1">MPKYDDFDLNLKQTSASNQKDTRVTSVMACTPGTCNNKCPN TNWLCSNVCVTKTCWTCA</td></tr><tr><td rowspan="1" colspan="1">PF05147.5</td></tr><tr><td rowspan="3" colspan="1"><italic>E. faecalis</italic> Fly1 cont1.76</td><td rowspan="3" colspan="1">leader_abc PF02052.7 leaderLanBC</td><td rowspan="1" colspan="1">context:</td><td rowspan="1" colspan="1">Lantibiotic:</td></tr><tr><td rowspan="1" colspan="1">PF04737.5 PF04738.5</td><td rowspan="2" colspan="1">MPKYDDFDLNLKQNVSSSNKEPRITSIKWCTPG TCNNTCKGDSTLKSNCCGGSLMCSLGGC</td></tr><tr><td rowspan="1" colspan="1">PF05147.5</td></tr><tr><td rowspan="2" colspan="1"><italic>Lyngbya</italic> sp PCC 8106</td><td rowspan="2" colspan="1">Trunkamide[1e-06]</td><td rowspan="1" colspan="1">Context:</td><td rowspan="1" colspan="1">Cyanobactin:</td></tr><tr><td rowspan="1" colspan="1">CyaG</td><td rowspan="1" colspan="1">MPCYPSYDGVDASVCMPCYPSYDGVDASVCMPCYP SYDDAE</td></tr><tr><td rowspan="3" colspan="1"><italic>B. pseudomallei</italic> 354a Contig0218</td><td rowspan="3" colspan="1">Capistruin[5e-23]</td><td rowspan="1" colspan="1">Context:</td><td rowspan="1" colspan="1">Lasso peptide:</td></tr><tr><td rowspan="1" colspan="1">PF13471.1</td><td rowspan="2" colspan="1">MVRFLAKLLRSTIHGSHGVSLDAVSSTHGTPGFQTPDARV ISRFGFN</td></tr><tr><td rowspan="1" colspan="1">PF00733.16</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec sec-type="methods">
      <title>Simple small ORF calling procedure facilitates genome mining</title>
      <p>A big problem when screening large amounts of genomic data using BAGEL2 was its dependence on the quality of the annotation. Multiple different ORF prediction procedures were therefore implemented. Consequently, several results had to be compared while still some of the small ORFs encoding antimicrobial peptides were lacking, creating the need for manual evaluation of some of the identified gene clusters. To remove this dependency, we now use a simple small ORF calling procedure for the AOIs identified by their context, obviating the need for reannotation and simplifying the procedure and the analyses.</p>
    </sec>
    <sec>
      <title>BAGEL3 is extensible</title>
      <p>The novel mining approach used in BAGEL3 has the big advantage that it can easily be extended to include new classes of modified peptides, the only requirement being that the gene of the small peptide of interest lies in a genomic context that can be recognized. The genomic context has to be translated into a simple rule that describes a certain AOI (for examples see <xref ref-type="table" rid="gkt391-T1">Table 1</xref>). The described precursor peptides should then be added to the database. If requirements for the precursor peptides are known (for example, must contain a cysteine), these can be added. The context rule should be tested to check if it is specific enough. Adding a new class of peptides to the system can be done in within a few hours if an extensive literature review is available. Users are encouraged to submit novel rules/classes via the online form available on the BAGEL3 web site.</p>
    </sec>
  </sec>
  <sec sec-type="conclusions">
    <title>CONCLUSIONS</title>
    <p>BAGEL3 is a versatile fast genome-mining tool valid not only for modified and non-modified bacteriocins but also for non-bactericidal RiPPs. It can handle large data sets like those from metagenome projects. This updated version looks for bacteriocins/RiPPs via two different approaches, which increases the success rate and lowers the need for manual evaluation of results. The new design also allows for easy inclusion of novel classes of peptides, and users are therefore encouraged to propose the addition of novel classes.</p>
  </sec>
</body>
<back>
  <ack>
    <title>ACKNOWLEDGEMENTS</title>
    <p>The authors thank Martijn Herber for maintaining the Linux servers and Marnix Medema for his useful suggestion of skipping ORF prediction all together. Additionally, the authors would like to thank the anonymous reviewers for the suggested features and rules that have been implemented.</p>
  </ack>
  <sec>
    <title>FUNDING</title>
    <p><funding-source>NWO-STW programme GenBiotics</funding-source> [project no.<award-id>10466</award-id> to A.G.v.H.]; ESF-ALW grant within the <funding-source>EuroSynBio programme SynMod</funding-source> (to M.M.-L.). Funding for open access charge: The <funding-source>Molecular Genetics</funding-source> group from the <funding-source>university of groningen GBB</funding-source>.</p>
    <p><italic>Conflict of interest statement.</italic> None declared.</p>
  </sec>
  <ref-list>
    <title>REFERENCES</title>
    <ref id="gkt391-B1">
      <label>1</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Arnison</surname>
            <given-names>PG</given-names>
          </name>
          <name>
            <surname>Bibb</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Bierbaum</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bowers</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Bugni</surname>
            <given-names>TS</given-names>
          </name>
          <name>
            <surname>Bulaj</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Camarero</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Campopiano</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Challis</surname>
            <given-names>GL</given-names>
          </name>
          <name>
            <surname>Clardy</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature</article-title>
        <source>Nat. Prod. Rep.</source>
        <year>2013</year>
        <volume>30</volume>
        <fpage>108</fpage>
        <lpage>160</lpage>
        <pub-id pub-id-type="pmid">23165928</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B2">
      <label>2</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cotter</surname>
            <given-names>PD</given-names>
          </name>
          <name>
            <surname>Ross</surname>
            <given-names>RP</given-names>
          </name>
          <name>
            <surname>Hill</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Bacteriocins—a viable alternative to antibiotics?</article-title>
        <source>Nat. Rev. Microbiol.</source>
        <year>2012</year>
        <volume>11</volume>
        <fpage>95</fpage>
        <lpage>105</lpage>
        <pub-id pub-id-type="pmid">23268227</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B3">
      <label>3</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Vélasquez</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>van der Donk</surname>
            <given-names>WA</given-names>
          </name>
        </person-group>
        <article-title>Evolution of lanthipeptide synthetases</article-title>
        <source>Proc. Natl Acad. Sci. USA</source>
        <year>2012</year>
        <volume>109</volume>
        <fpage>18361</fpage>
        <lpage>18366</lpage>
        <pub-id pub-id-type="pmid">23071302</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B4">
      <label>4</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Freeman</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>Gurgui</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Helf</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Morinaka</surname>
            <given-names>BI</given-names>
          </name>
          <name>
            <surname>Uria</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Oldham</surname>
            <given-names>NJ</given-names>
          </name>
          <name>
            <surname>Sahl</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Matsunaga</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Piel</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Metagenome mining reveals polytheonamides as posttranslationally modified ribosomal peptides</article-title>
        <source>Science</source>
        <year>2012</year>
        <volume>338</volume>
        <fpage>387</fpage>
        <lpage>390</lpage>
        <pub-id pub-id-type="pmid">22983711</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B5">
      <label>5</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Oman</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Boettcher</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Okalibe</surname>
            <given-names>XN</given-names>
          </name>
          <name>
            <surname>van der Donk</surname>
            <given-names>WA</given-names>
          </name>
        </person-group>
        <article-title>Sublancin is not a lantibiotic but an S-linked glycopeptide</article-title>
        <source>Nat. Chem. Biol.</source>
        <year>2011</year>
        <volume>7</volume>
        <fpage>78</fpage>
        <lpage>80</lpage>
        <pub-id pub-id-type="pmid">21196935</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B6">
      <label>6</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huo</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Rachid</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Stadler</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wenzel</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Müller</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Synthetic biotechnology to study and engineer ribosomal bottromycin biosynthesis</article-title>
        <source>Chem. Biol.</source>
        <year>2012</year>
        <volume>19</volume>
        <fpage>1278</fpage>
        <lpage>1287</lpage>
        <pub-id pub-id-type="pmid">23021914</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B7">
      <label>7</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van Heel</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Mu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Montalbán-López</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hendriks</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Kuipers</surname>
            <given-names>OP</given-names>
          </name>
        </person-group>
        <article-title>Designing and producing modified, new-to-nature, peptides with antimicrobial activity by use of a combination of various lantibiotic modification enzymes</article-title>
        <source>ACS Synth. Biol.</source>
        <year>2013</year>
        <comment>doi: 10.1021/sb3001084</comment>
      </element-citation>
    </ref>
    <ref id="gkt391-B8">
      <label>8</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kluskens</surname>
            <given-names>LD</given-names>
          </name>
          <name>
            <surname>Nelemans</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Rink</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>de Vries</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Meter-Arkema</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Walther</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kuipers</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Moll</surname>
            <given-names>GN</given-names>
          </name>
          <name>
            <surname>Haas</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Angiotensin-(1-7) with thioether bridge: an angiotensin-converting enzyme-resistant, potent angiotensin-(1-7) analog</article-title>
        <source>J. Pharmacol. Exp. Ther.</source>
        <year>2009</year>
        <volume>328</volume>
        <fpage>849</fpage>
        <lpage>854</lpage>
        <pub-id pub-id-type="pmid">19038778</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B9">
      <label>9</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Maksimov</surname>
            <given-names>MO</given-names>
          </name>
          <name>
            <surname>Pelczer</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Link</surname>
            <given-names>AJ</given-names>
          </name>
        </person-group>
        <article-title>Precursor-centric genome-mining approach for lasso peptide discovery</article-title>
        <source>Proc. Natl Acad. Sci. USA</source>
        <year>2012</year>
        <volume>109</volume>
        <fpage>15223</fpage>
        <lpage>15228</lpage>
        <pub-id pub-id-type="pmid">22949633</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B10">
      <label>10</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Claesen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bibb</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Genome mining and genetic analysis of cypemycin biosynthesis reveal an unusual class of posttranslationally modified peptides</article-title>
        <source>Proc. Natl Acad. Sci. USA</source>
        <year>2010</year>
        <volume>107</volume>
        <fpage>16297</fpage>
        <lpage>16302</lpage>
        <pub-id pub-id-type="pmid">20805503</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B11">
      <label>11</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Velásquez</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Van Der Donk</surname>
            <given-names>WA</given-names>
          </name>
        </person-group>
        <article-title>Genome mining for ribosomally synthesized natural products</article-title>
        <source>Curr. Opin. Chem. Biol.</source>
        <year>2011</year>
        <volume>15</volume>
        <fpage>11</fpage>
        <lpage>21</lpage>
        <pub-id pub-id-type="pmid">21095156</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B12">
      <label>12</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>SW</given-names>
          </name>
          <name>
            <surname>Mitchell</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Markley</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Hensler</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Gonzalez</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Wohlrab</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Dorrestein</surname>
            <given-names>PC</given-names>
          </name>
          <name>
            <surname>Nizet</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Dixon</surname>
            <given-names>JE</given-names>
          </name>
        </person-group>
        <article-title>Discovery of a widely distributed toxin biosynthetic gene cluster</article-title>
        <source>Proc. Natl Acad. Sci. USA</source>
        <year>2008</year>
        <volume>105</volume>
        <fpage>5879</fpage>
        <lpage>5884</lpage>
        <pub-id pub-id-type="pmid">18375757</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B13">
      <label>13</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>de Jong</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>van Hijum</surname>
            <given-names>SAFT</given-names>
          </name>
          <name>
            <surname>Bijlsma</surname>
            <given-names>JJE</given-names>
          </name>
          <name>
            <surname>Kok</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kuipers</surname>
            <given-names>OP</given-names>
          </name>
        </person-group>
        <article-title>BAGEL: a web-based bacteriocin genome mining tool</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2006</year>
        <volume>34</volume>
        <fpage>W273</fpage>
        <pub-id pub-id-type="pmid">16845009</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B14">
      <label>14</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>de Jong</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>van Heel</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Kok</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kuipers</surname>
            <given-names>OP</given-names>
          </name>
        </person-group>
        <article-title>BAGEL2: mining for bacteriocins in genomic data</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2010</year>
        <volume>38</volume>
        <fpage>W647</fpage>
        <lpage>W651</lpage>
        <pub-id pub-id-type="pmid">20462861</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B15">
      <label>15</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hammami</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Zouhir</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Le Lay</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Hamida</surname>
            <given-names>JB</given-names>
          </name>
          <name>
            <surname>Fliss</surname>
            <given-names>I</given-names>
          </name>
        </person-group>
        <article-title>BACTIBASE second release: a database and tool platform for bacteriocin characterization</article-title>
        <source>BMC Microbiol.</source>
        <year>2010</year>
        <volume>10</volume>
        <fpage>22</fpage>
        <pub-id pub-id-type="pmid">20105292</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B16">
      <label>16</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Medema</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Blin</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Cimermancic</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>de Jager</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Zakrzewski</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Fischbach</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Weber</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Takano</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Breitling</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>antiSMASH: Rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2011</year>
        <volume>39</volume>
        <fpage>W339</fpage>
        <lpage>W346</lpage>
        <pub-id pub-id-type="pmid">21672958</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B17">
      <label>17</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schmidt</surname>
            <given-names>EW</given-names>
          </name>
          <name>
            <surname>Nelson</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>Rasko</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Sudek</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Eisen</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Haygood</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Ravel</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Patellamide A and C biosynthesis by a microcin-like pathway in prochloron didemni, the cyanobacterial symbiont of lissoclinum patella</article-title>
        <source>Proc. Natl Acad. Sci. USA</source>
        <year>2005</year>
        <volume>102</volume>
        <fpage>7315</fpage>
        <lpage>7320</lpage>
        <pub-id pub-id-type="pmid">15883371</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B18">
      <label>18</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rea</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Sit</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Clayton</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>O'Connor</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Whittal</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Vederas</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Ross</surname>
            <given-names>RP</given-names>
          </name>
          <name>
            <surname>Hill</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against clostridium difficile</article-title>
        <source>Proc. Natl Acad. Sci. USA</source>
        <year>2010</year>
        <volume>107</volume>
        <fpage>9352</fpage>
        <lpage>9357</lpage>
        <pub-id pub-id-type="pmid">20435915</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B19">
      <label>19</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Delcher</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Bratke</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>Powers</surname>
            <given-names>EC</given-names>
          </name>
          <name>
            <surname>Salzberg</surname>
            <given-names>SL</given-names>
          </name>
        </person-group>
        <article-title>Identifying bacterial genes and endosymbiont DNA with glimmer</article-title>
        <source>Bioinformatics</source>
        <year>2007</year>
        <volume>23</volume>
        <fpage>673</fpage>
        <lpage>679</lpage>
        <pub-id pub-id-type="pmid">17237039</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B20">
      <label>20</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Altschul</surname>
            <given-names>SF</given-names>
          </name>
          <name>
            <surname>Gish</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Myers</surname>
            <given-names>EW</given-names>
          </name>
          <name>
            <surname>Lipman</surname>
            <given-names>DJ</given-names>
          </name>
        </person-group>
        <article-title>Basic local alignment search tool</article-title>
        <source>J. Mol. Biol.</source>
        <year>1990</year>
        <volume>215</volume>
        <fpage>403</fpage>
        <lpage>410</lpage>
        <pub-id pub-id-type="pmid">2231712</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B21">
      <label>21</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schmidt</surname>
            <given-names>EW</given-names>
          </name>
          <name>
            <surname>Nelson</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>Rasko</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Sudek</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Eisen</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Haygood</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Ravel</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Patellamide A and C biosynthesis by a microcin-like pathway in prochloron didemni, the cyanobacterial symbiont of lissoclinum patella</article-title>
        <source>Proc. Natl Acad. Sci. USA</source>
        <year>2005</year>
        <volume>102</volume>
        <fpage>7315</fpage>
        <lpage>7320</lpage>
        <pub-id pub-id-type="pmid">15883371</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B22">
      <label>22</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Izquierdo</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Wagner</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Marchioni</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Aoude-Werner</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ennahar</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Enterocin 96, a novel class II bacteriocin produced by enterococcus faecalis WHE 96, isolated from munster cheese</article-title>
        <source>Appl. Environ. Microbiol.</source>
        <year>2009</year>
        <volume>75</volume>
        <fpage>4273</fpage>
        <lpage>4276</lpage>
        <pub-id pub-id-type="pmid">19411428</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B23">
      <label>23</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Stepper</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Shastri</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Loo</surname>
            <given-names>TS</given-names>
          </name>
          <name>
            <surname>Preston</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Novak</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Man</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Moore</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Havlcek</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Patchett</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Norris</surname>
            <given-names>GE</given-names>
          </name>
        </person-group>
        <article-title>Cysteine S-glycosylation, a new post-translational modification found in glycopeptide bacteriocins</article-title>
        <source>FEBS Lett.</source>
        <year>2011</year>
        <volume>585</volume>
        <fpage>645</fpage>
        <lpage>650</lpage>
        <pub-id pub-id-type="pmid">21251913</pub-id>
      </element-citation>
    </ref>
    <ref id="gkt391-B24">
      <label>24</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Knappe</surname>
            <given-names>TA</given-names>
          </name>
          <name>
            <surname>Linne</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Zirah</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rebuffat</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Marahiel</surname>
            <given-names>MA</given-names>
          </name>
        </person-group>
        <article-title>Isolation and structural characterization of capistruin, a lasso peptide predicted from the genome sequence of burkholderia thailandensis E264</article-title>
        <source>J. Am. Chem. Soc.</source>
        <year>2008</year>
        <volume>130</volume>
        <fpage>11446</fpage>
        <lpage>11454</lpage>
        <pub-id pub-id-type="pmid">18671394</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
